Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical data support first-in-human trial of NBTXR-3

Oct. 13, 2011

Portuguese study identifies new biomarker for prognosis of ovarian cancer

Oct. 13, 2011

Preclinical and clinical data presented on AZD-5847 for tuberculosis

Oct. 13, 2011

Viamet Pharmaceuticals' antifungals show promise in models of candidiasis and dermatophytosis

Oct. 13, 2011

Twelve-month data presented from IMPACT-DCM trial

Oct. 11, 2011

MedImmune completes phase II tralokinumab trial

Oct. 11, 2011

Japanese team identifies new biomarker of pulmonary emphysema

Oct. 11, 2011

First-in-human data presented on risperidone-ISM formulation

Oct. 11, 2011

GlycoVax discloses preclinical data on its proprietary glycoprotein vaccines

Oct. 11, 2011

Tetraphase Pharmaceuticals describes multiple novel tetracyclines

Oct. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...